Johnson & Johnson(JNJ)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $173.33 – $281.07
- YTD
- +32.74%
- IV Rank (30D)
- 26.16
- Straddle Price
- $13.10
- P/C Vol Ratio
- 2.65
- Market Cap
- $663.3B
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.79% |
| Beta vs SPY | 0.46 |
| Cost of Equity (CAPM) | 7.10% (VRP-adj) |
| WACC | 9.34% |
| Volatility Risk Premium | +22.3pp (IV − HV30) |
| Effective Tax Rate | 16.5% |
| Rev. Growth (YoY, DCF input) | +5.5% |
| DCF Horizon | 12 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.05 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $22.2B |
| Return on Equity (TTM) | 24.8% |
| Book / Price | 12.7% |
| Gross Margin (TTM) | 67.9% |
| FCF Margin (TTM) | 22.7% |
| Debt / Equity | 0.44 |
| Quality Score | 5/6 — high quality (12y DCF) |
| Market-Implied Growth | +13.9% (reverse-DCF on current price) |
| SMA 50 | $261.75 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $268.26 |
| Bollinger Width / SMA20 | 3.1% (drives anchor stability) |
| Net Debt | $16.9B |
| Market Cap | $670B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $158.36 | 19% | |
| DDM (Gordon) | $264.58 | 0% | |
| Peer P/E | $344.72 | 9% | median 37.9× · 7 peers |
| Peer EV/EBITDA | $252.61 | 9% | median 17.7× · 8 peers |
| Peer P/B | $312.56 | 2% | median 9.0× · 7 peers |
| Peer P/S | $250.43 | 6% | median 5.9× · 8 peers |
| Market Anchor (SMA50) | $261.75 | 38% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $253.85 | 19% | 28 strikes · skew -0.57 |
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834)
- Exchange
- XNYS
- Market Cap
- $663.3B
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -0.06% | 23 |
| Feb | -0.33% | 23 |
| Mar | +1.27% | 23 |
| Apr | +1.56% | 23 |
| May | -0.87% | 23 |
| Jun | +1.35% | 23 |
| Jul | +2.48% | 23 |
| Aug | -0.10% | 23 |
| Sep | +0.14% | 24 |
| Oct | +0.85% | 23 |
| Nov | +0.88% | 23 |
| Dec | +0.77% | 23 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-10-15 | Pre-Market | 2.64% | 1.34% | 0.51x | Within |
| 2025-01-22 | Pre-Market | 2.42% | 2.20% | 0.91x | Within |
| 2025-04-15 | Pre-Market | 2.70% | 0.32% | 0.12x | Within |
| 2025-07-16 | Pre-Market | 2.57% | 6.03% | 2.35x | Exceeded |
| 2025-10-14 | Pre-Market | 3.23% | 0.06% | 0.02x | Within |
| 2026-01-21 | Pre-Market | 3.25% | 0.04% | 0.01x | Within |
| 2026-04-14 | Pre-Market | 3.51% | 0.90% | 0.26x | Within |
| 2026-07-15 | Pre-Market | 3.37% | 2.69% | 0.80x | Within |
- IV Rank (30D)
- 26.16
- IV Rank (7D)
- 100
- Avg IV
- 43.7%
- Straddle (30D)
- $13.10
- Straddle (7D)
- $6.03
- P/C Volume
- 2.65
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- -0.20
- Correlation (SPY)
- -13.4%
- R²
- 0.02
- Ann. Volatility
- 19.2%
- SPY Volatility
- 12.8%
Negative beta - stock moves opposite to market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $969.20M | 18.32% | 2026-06-30 |
| 2 | CITADEL ADVISORS LLC Custodian | $933.01M | 17.64% | 2026-06-30 |
| 3 | JANE STREET GROUP, LLC Custodian | $702.96M | 13.29% | 2026-06-30 |
| 4 | JPMORGAN CHASE & CO Custodian | $328.70M | 6.21% | 2026-06-30 |
| 5 | ROYAL BANK OF CANADA Custodian | $324.45M | 6.13% | 2026-06-30 |
| 6 | D. E. Shaw & Co., Inc. Custodian | $217.32M | 4.11% | 2026-06-30 |
| 7 | PEAK6 LLC | $186.67M | 3.53% | 2026-06-30 |
| 8 | IMC-Chicago, LLC Custodian | $180.70M | 3.42% | 2026-06-30 |
| 9 | WOLVERINE TRADING, LLC Custodian | $136.00M | 2.57% | 2025-09-30 |
| 10 | MILLENNIUM MANAGEMENT LLC Custodian | $111.57M | 2.11% | 2026-06-30 |
| 11 | Walleye Trading LLC | $94.55M | 1.79% | 2026-06-30 |
| 12 | CITIGROUP INC Custodian | $91.63M | 1.73% | 2026-06-30 |
| 13 | NATIONAL BANK OF CANADA /FI/ Custodian | $88.89M | 1.68% | 2026-06-30 |
| 14 | GROUP ONE TRADING LLC Custodian | $73.45M | 1.39% | 2026-06-30 |
| 15 | UBS Group AG Custodian | $70.32M | 1.33% | 2026-06-30 |
| 16 | Point72 Asset Management, L.P. | $65.09M | 1.23% | 2026-06-30 |
| 17 | Squarepoint Ops LLC | $62.17M | 1.18% | 2026-06-30 |
| 18 | Walleye Capital LLC | $48.18M | 0.91% | 2026-06-30 |
| 19 | SIMPLEX TRADING, LLC Custodian | $47.42M | 0.90% | 2026-06-30 |
| 20 | Alphadyne Asset Management LP | $43.07M | 0.81% | 2026-06-30 |
| 21 | WELLS FARGO & COMPANY/MN Custodian | $41.58M | 0.79% | 2026-03-31 |
| 22 | Gladius Capital Management LP | $39.97M | 0.76% | 2026-06-30 |
| 23 | Man Group plc | $38.10M | 0.72% | 2026-06-30 |
| 24 | GOLDMAN SACHS GROUP INC Custodian | $36.14M | 0.68% | 2026-06-30 |
| 25 | BNP PARIBAS FINANCIAL MARKETS Custodian | $36.14M | 0.68% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian | $1.01B | 18.00% | 2026-06-30 |
| 2 | JANE STREET GROUP, LLC Custodian | $974.91M | 17.43% | 2026-06-30 |
| 3 | CITADEL ADVISORS LLC Custodian | $816.26M | 14.60% | 2026-06-30 |
| 4 | Point72 Asset Management, L.P. | $483.84M | 8.65% | 2026-06-30 |
| 5 | CITIGROUP INC Custodian | $461.44M | 8.25% | 2026-06-30 |
| 6 | MILLENNIUM MANAGEMENT LLC Custodian | $287.19M | 5.14% | 2026-06-30 |
| 7 | IMC-Chicago, LLC Custodian | $184.84M | 3.31% | 2026-06-30 |
| 8 | NOMURA HOLDINGS INC | $136.51M | 2.44% | 2026-06-30 |
| 9 | UBS Group AG Custodian | $115.67M | 2.07% | 2026-06-30 |
| 10 | BNP PARIBAS FINANCIAL MARKETS Custodian | $94.10M | 1.68% | 2026-06-30 |
| 11 | JPMORGAN CHASE & CO Custodian | $90.84M | 1.62% | 2026-06-30 |
| 12 | CAPSTONE INVESTMENT ADVISORS, LLC | $90.08M | 1.61% | 2026-06-30 |
| 13 | GROUP ONE TRADING LLC Custodian | $87.37M | 1.56% | 2026-06-30 |
| 14 | Alphadyne Asset Management LP | $61.79M | 1.10% | 2026-06-30 |
| 15 | Qube Research & Technologies Ltd | $59.43M | 1.06% | 2026-06-30 |
| 16 | WOLVERINE TRADING, LLC Custodian | $56.12M | 1.00% | 2025-09-30 |
| 17 | Eisler Capital Management Ltd. | $50.43M | 0.90% | 2025-09-30 |
| 18 | SIMPLEX TRADING, LLC Custodian | $45.05M | 0.81% | 2026-06-30 |
| 19 | D. E. Shaw & Co., Inc. Custodian | $39.49M | 0.71% | 2026-06-30 |
| 20 | Man Group plc | $38.10M | 0.68% | 2026-06-30 |
| 21 | Allianz Asset Management GmbH | $34.46M | 0.62% | 2026-06-30 |
| 22 | Parallax Volatility Advisers, L.P. | $33.02M | 0.59% | 2026-06-30 |
| 23 | Squarepoint Ops LLC | $32.76M | 0.59% | 2026-06-30 |
| 24 | CAPITAL FUND MANAGEMENT S.A. | $30.70M | 0.55% | 2026-06-30 |
| 25 | Walleye Trading LLC | $30.50M | 0.55% | 2026-06-30 |
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Timothy Schmid | EVP, WW Chair, MedTech | Mixed | — | $209.87 | -$4.36M | EDGAR |
| 2026-08-18 | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Mixed | — | $189.51 | -$2.22M | EDGAR |
| 2026-08-14 | Joaquin Duato | CEO and Chairman of the Board | Mixed | — | $188.42 | -$17.94M | EDGAR |
| 2026-08-07 | Elizabeth Forminard | EVP, Chief Legal Officer | Mixed | −6,574 | $210.74 | -$2.86M | EDGAR |
| 2026-08-07 | Joaquin Duato | CEO and Chairman of the Board | Sell (S) | −48,480 | $258.15 | -$12.52M | EDGAR |
| 2026-08-07 | Joaquin Duato | CEO and Chairman of the Board | Sell (S) | −48,480 | $258.15 | -$12.52M | EDGAR |
| 2026-08-07 | Elizabeth Forminard | EVP, Chief Legal Officer | Mixed | −6,574 | $210.74 | -$2.86M | EDGAR |
| 2026-07-21 | Vanessa Broadhurst | EVP, Global Corp Affairs | Mixed | — | $191.02 | -$2.78M | EDGAR |
| 2023-07-27 | William Hait | See Remarks | Mixed | — | $131.22 | -$1.20M | EDGAR |
| 2023-07-27 | Peter Fasolo | Exec VP, Chief HR Officer | Sell (S) | −20,000 | $170.32 | -$3.41M | EDGAR |
| 2023-06-14 | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Sell (S) | −12,465 | $160.00 | -$1.99M | EDGAR |
| 2023-06-08 | MARILLYN A HEWSON | Director | Grant (A) | +230 RSU | — | EDGAR | |
| 2023-05-25 | Joseph J Wolk | Exec VP, CFO | Gift (G) | −55 | — | EDGAR | |
| 2023-05-02 | Darius Adamczyk | Director | Grant (A) | +1,193 RSU | — | EDGAR | |
| 2023-05-02 | D SCOTT DAVIS | Director | Grant (A) | +1,193 RSU | — | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Alex Gorsky | Chairman, CEO | 1,133,871 | $312.08M | -$38.60M | 29 | 2023-01-18 |
| 2 | Joaquin Duato | CEO and Chairman of the Board | 379,300 | $104.39M | -$69.19M | 20 | 2026-08-14 |
| 3 | WILLIAM C WELDON | Chairman/CEO | 354,009 | $97.43M | -$117.93M | 44 | 2013-02-12 |
| 4 | Paulus Stoffels | Vice Chair, Exec Committee | 289,864 | $79.78M | -$72.29M | 25 | 2021-02-17 |
| 5 | Jennifer L Taubert | EVP, WWC. Innovative Medicine | 209,451 | $57.65M | -$17.55M | 12 | 2026-08-18 |
| 6 | ROBERT J DARRETTA | Vice Chairman | 209,056 | $57.54M | $0 | 2 | 2007-02-21 |
| 7 | Dominic J Caruso | Exec VP, Finance; CFO | 177,871 | $48.96M | -$31.26M | 52 | 2018-02-14 |
| 8 | Michael H Ullmann | Exec VP, General Counsel | 160,121 | $44.07M | -$7.64M | 28 | 2022-02-17 |
| 9 | RUSSELL C DEYO | VP, General Counsel | 143,921 | $39.61M | -$28.98M | 35 | 2012-02-23 |
| 10 | COLLEEN A GOGGINS | Member, Executive Committee | 108,014 | $29.73M | -$8.00M | 32 | 2011-01-12 |
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | Taubert Jennifer L | Officer | 15,000 | $3.95M | 2026-08-17 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-13 | Duato Joaquin | Officer, Director | 123,291 | $32.20M | 2026-08-13 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-06 | Forminard Elizabeth | Officer | 15,918 | $4.09M | 2026-08-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-05 | Joaquin Duato | CEO, Chariman | 48,480 | $12.36M | 2026-08-05 | J.P. Morgan Securities LLC | — | EDGAR |
| 2026-07-20 | Broadhurst Vanessa | Officer | 23,054 | $5.79M | 2026-07-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-06-11 | Wengel Kathryn E | Officer | 10,000 | $2.40M | 2026-06-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-27 | Decker Robert J | Officer | 4,075 | $1.01M | 2026-02-27 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-20 | Schmid Timothy | Officer | 1,322 | $324.8K | 2026-02-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-18 | Schmid Timothy | Officer | 22,623 | $5.53M | 2026-02-18 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-02-17 | Broadhurst Vanessa | Officer | 6,197 | $1.51M | 2026-02-17 | Fidelity Brokerage Services LLC | — | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-28 | 0000200406-26-000089 | EDGAR |
| 2026-04-14 | 0000200406-26-000076 | EDGAR |
| 2026-01-21 | 0000200406-26-000002 | EDGAR |
| 2025-10-14 | 0000200406-25-000201 | EDGAR |
| 2025-09-09 | 0000200406-25-000190 | EDGAR |
| 2025-07-16 | 0000200406-25-000170 | EDGAR |
| 2025-06-10 | 0000200406-25-000152 | EDGAR |
| 2025-04-30 | 0000200406-25-000141 | EDGAR |
| 2025-04-15 | 0000200406-25-000110 | EDGAR |
| 2025-04-03 | 0000200406-25-000106 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-11 | 0000200406-26-000016 | EDGAR |
| 2025-02-13 | 0000200406-25-000038 | EDGAR |
| 2024-02-16 | 0000200406-24-000013 | EDGAR |
| 2023-02-16 | 0000200406-23-000016 | EDGAR |
| 2022-02-17 | 0000200406-22-000022 | EDGAR |
| 2021-02-22 | 0000200406-21-000008 | EDGAR |
| 2020-02-18 | 0000200406-20-000010 | EDGAR |
| 2019-02-20 | 0000200406-19-000009 | EDGAR |
| 2018-02-21 | 0000200406-18-000005 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-04-22 | 0000200406-26-000087 | EDGAR |
| 2025-10-22 | 0000200406-25-000209 | EDGAR |
| 2025-07-24 | 0000200406-25-000178 | EDGAR |
| 2025-04-23 | 0000200406-25-000119 | EDGAR |
| 2024-10-23 | 0000200406-24-000096 | EDGAR |
| 2024-07-25 | 0000200406-24-000075 | EDGAR |
| 2024-05-01 | 0000200406-24-000049 | EDGAR |
| 2023-10-27 | 0000200406-23-000102 | EDGAR |
| 2023-07-31 | 0000200406-23-000082 | EDGAR |
| 2023-04-28 | 0000200406-23-000056 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
| P/E Ratio | 31.9 |
| P/B Ratio | 7.8 |
| P/S Ratio | 6.8 |
| EV/EBITDA | 20.4 |
| TTM Revenue | $97.9B |
| TTM Net Income | $21.0B |
| TTM EPS | $8.62 |
| ROE | 24.8% |
| Dividend Yield | 1.90% |
| Debt/Equity | 0.58 |